The FDA announced on May 17, 2024, that Siemens Healthcare Diagnostics Inc is recalling software version 5.3 for the RAPIDPoint 500e Blood Gas System due to a labeling error. This issue may cause capillary samples to be incorrectly identified as arterial in laboratory information systems, potentially leading to incorrect diagnoses.
How to tell if you have it
- RAPIDPoint 500e Blood Gas System (USA), Siemens Material Number: 11416751
- RAPIDPoint 500e Blood Gas System (China), Siemens Material Number: 11416752
- RAPIDPoint 500e Blood Gas System (Japan), Siemens Material Number: 11416754
- RAPIDPoint 500e Blood Gas System (ROW), Siemens Material Number: 11416755
The hazard
According to the FDA, software version 5.3 incorrectly labels capillary samples as arterial when displayed on the LIS. This error may lead to results being flagged according to an established arterial range, which could result in incorrect diagnoses and management decisions.
Context
GovInfoNow's records show Siemens Healthcare Diagnostics, Inc. has 150 other recalls on record since June 7, 2017. On Aug. 17, 2026, Siemens issued a recall for the Atellica CH RCRP Test due to the potential for falsely elevated results. On July 13, 2026, Beckman Coulter recalled the Emit 2000 Quinidine Assay because of unacceptable precision performance that may lead to erroneously elevated quinidine measurements. On July 6, 2026, Siemens recalled the Atellica CH Urine Albumin test due to risks of falsely depressed results for Urea Nitrogen and Enzymatic Hemoglobin A.